logo
welcome
Reuters

Reuters

Astellas' gastric cancer therapy gets UK regulator's nod

Reuters
Summary
Nutrition label

80% Informative

Britain 's health regulator approves Astellas Pharma's therapy to treat a type of gastric cancer.

Monoclonal antibody, which can attach itself to certain cancer cells and destroy them, was approved in combination with a standard chemotherapy for adults with cancer in the stomach or the junction where the oesophagus joins the stomach.

VR Score

88

Informative language

92

Neutral language

83

Article tone

formal

Language

English

Language complexity

69

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links